Key facts
- This page summarizes Scott D. Grimes's Form 4 filing for Cardlytics, Inc. (CDLX).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Jan 2022, 15:21.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021.
Footnote F2
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.41 to $65.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6) to this Form 4.
Footnote F3
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.44 to $66.43, inclusive.
Footnote F4
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $66.49 to $67.25, inclusive.
Footnote F5
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.55 to $68.51, inclusive.
Footnote F6
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.57 to $68.86, inclusive.
Footnote F7
The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
Footnote F8
The reportable securities are held by the 2013 Scott Grimes GRAT UAD.